BONJESTA FDA approval date

The FDA approved BONJESTA on 7 Nov 2016.

FDA approval date
7 Nov 2016

Drug identity has not yet been verified against registry records

Also recorded as DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-11-07DayBONJESTAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209661", "applicant_as_listed_by_fda": "DUCHESNAY", "brand_names": ["BONJESTA"], "active_ingredients": ["DOXYLAMINE SUCCINATE", "PYRIDOXINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20161107", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026